semaglutide and beta blockers For a type 2 diabetic patient with eGFR ≈40 mL/min/1.73 m² who is taking metformin, a sulfonylurea, basal insulin, an SGLT2 inhibitor, an ACE‑inhibitor/ARB, a beta‑blocker, a diuretic, a statin, how Tirzepatide and Beta Blockers: Safety
Description
Semaglutide, marketed as Ozempic for diabetes and Wegovy for weight loss, has become one of the most widely recognized GLP-1 medications
This saves you time and frustration, ensuring a smooth process
Consult with a healthcare professional to discuss any concerns and receive personalized guidance
Additionally, metformin requires regular kidney function monitoring, and patients with declining renal function may need to reduce or eliminate it regardless of other medications
